Ingredients for Society
Our primary specialization lies in the development of synthesis routes and
manufacturing of highly potent Active Pharmaceutical Ingredients (APIs),
primarily used in cancer therapies
Products
Excellence in API Manufacturing: Superior Purity, Stability, and Efficiency at Synbias-Gemini Group
The quality and purity of APIs are critical factors in pharmaceutical manufacturing, impacting both the efficacy and safety of final drug formulations. Synbias-Pharma Group distinguished themselves in the pharmaceutical industry by producing APIs that exceed pharmacopoeial standards and offer enhanced stability and efficiency.
Read Moreof the world market of particular API
Our APIs are shipped to customers in 21 countries
Successfully passed through FDA, Anvisa, cGMP and others
Inspections
Compliance You Can Trust
At Synbias-Gemini Group, we have a distinguished track record with global regulatory agencies, demonstrating our unwavering commitment to compliance and quality. Our collaborative approach ensures robust support to our customers through all phases of regulatory submission, ensuring that every product we manufacture meets the highest standards.
Inspection History (2012-2024)
- Germany Regierungspräsidium Tübingen (German authority): 8 inspections
- US FDA: 1 inspection
Anthracyclines
Nucleosides
Company
Our mission is to advance global health
The Synbias-Gemini Group operates under the umbrella of Synbias Pharma AG, headquartered in Schaffhausen, Switzerland, which 100% shareholder of Gemini PharmChem Mannheim GmbH, our production facilities, a highly esteemed manufacturing and R&D site located in Mannheim, Germany.
Read more
